MedPath

Capsule Repair After Arthroscopic Surgery of the Hip

Not Applicable
Completed
Conditions
Femoroacetabular Impingement
Musculoskeletal - Other muscular and skeletal disorders
Surgery - Surgical techniques
Registration Number
ACTRN12615000680561
Lead Sponsor
Matthew Brick
Brief Summary

This trial looked at post op MRI scans of patients undergoing hip arthroscopy. The patients were randomised to 1. having their capsulotomy repaired and 2. not having their capsulotomy repaired. MRI scans did not show any difference. Both groups showed repaired capsules at 24 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion Criteria
(1) Male or female patients aged between 18-51
(2) Healthy patients undergoing hip arthroscopy due to Cam or
mixed FAI
(3) No major osteoarthritic (OA) changes according to X-Ray
and surgery observation (Tonnis 0-1)
(4) No previous hip surgery
(5) No other influential disabilities in lower limbs
(6) No chronic use of NSAID, analgesics, steroids or
chemotherapy drugs
(7) Base line activity level (Tegner 3 and above)

Exclusion Criteria

Exclusion Criteria
(1) Patients with concomitant disease that may affect joints
(2) Patients with major ligamentous laxity
(3) Patients who have undergone only minor vertical
capsulotomy (as in small pincer only lesions)
(4) Patients with extreme range of motion needs (such as ballet
dancers)
(5) Patients suffering from connective tissue disease
(6) Patients suffering from bilateral symptomatic FAI that are
being operated on for their first hip
(7) Patients with relative or proven dysplastic hip determined by
center edge angle and/or extreme version abnormalities as
measured on apical CT/MR cuts and pelvic XR
(8) Patients who needed Ilio-Psoas release
(9) Patients whose cartilage hip status was defined as advanced
OA during surgery
(10) Patients who following surgery would be instructed to avoid
full weight bearing on the operated hip for more than 4
weeks
(11) Concomitant use of PRP (platelet rich plasma) or hyaluronic acid

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(1) iHOT Version 12 <br>This is a validated patient generated subjective outcome measure of hip function.<br>[6 weeks, 6 months, 1 year, 2 years];(2) Marx activity score<br>[3,6,12 and 24 months];(3) ROM and stability testing.<br>[3,6,12 and 24 months]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath